InformEx 2014 Kicks Off in Miami Beach - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

InformEx 2014 Kicks Off in Miami Beach


InformEx, North America's business partnering event for buyers and sellers of high-value chemistry, has launched the 30th edition of its annual conference at the Miami Beach Convention Center. The conference continues through Jan. 24, featuring on-site education sessions and daily networking events geared toward helping attendees grow their business and prepare for the changing marketplace.

More than 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical companies are taking part in the conference. On-floor education sessions allow attendees to learn about key topics such as green chemistry, opportunities in pharma, personalized medicine, compliance, 3-D printing and more.
Kicking off the conference sessions on Jan. 22 will be a special presentation by Dr. Donna Nelson, University of Oklahoma organic chemistry professor who was a scientific consultant for the Emmy-winning series "Breaking Bad" since its second season. Dr. Nelson will share stories of how she turned her chemistry knowledge into plot-enhancing details for what has been one of the most successful shows of the last decade.


Source: InformEx

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here